nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A mechanism-based binding model for the population pharmacokinetics and pharmacodynamics of omalizumab
|
Hayashi, Naoto |
|
2007 |
63 |
5 |
p. 548-561 |
artikel |
2 |
Assessment of renal function in clinical practice at the bedside of burn patients
|
Conil, J. M. |
|
2007 |
63 |
5 |
p. 583-594 |
artikel |
3 |
Authors' response: Poor correlation between 6β-hydroxycortisol:cortisol molar ratios and midazolam clearance as measure of hepatic CYP3A activity: a comment
|
Chen, Ya-Chi |
|
2007 |
63 |
5 |
p. 633 |
artikel |
4 |
Bayesian modelling and ROC analysis to predict placebo responders using clinical score measured in the initial weeks of treatment in depression trials
|
Gomeni, Roberto |
|
2007 |
63 |
5 |
p. 595-613 |
artikel |
5 |
Drug therapy in kidney disease
|
Aronson, Jeffrey K |
|
2007 |
63 |
5 |
p. 509-511 |
artikel |
6 |
Effects of gastric emptying on oral mycophenolic acid pharmacokinetics in stable renal allograft recipients
|
Naesens, Maarten |
|
2007 |
63 |
5 |
p. 541-547 |
artikel |
7 |
Erratum
|
|
|
2007 |
63 |
5 |
p. 635 |
artikel |
8 |
Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers
|
van Doorn, Martijn |
|
2007 |
63 |
5 |
p. 562-574 |
artikel |
9 |
Palatability of angiotensin II antagonists among nephropathic children
|
Meier, Chiara M. |
|
2007 |
63 |
5 |
p. 628-631 |
artikel |
10 |
Pharmacokinetics and safety assessments of high-dose and 4-week treatment with S-3304, a novel matrix metalloproteinase inhibitor, in healthy volunteers
|
Mant, Timothy G. K. |
|
2007 |
63 |
5 |
p. 512-526 |
artikel |
11 |
Pharmacokinetics of a novel agent, R667, in patients with emphysema
|
Chiu, Yu-Yuan |
|
2007 |
63 |
5 |
p. 527-533 |
artikel |
12 |
Pharmacokinetics of desloratadine in children between 2 and 11 years of age
|
Gupta, Samir |
|
2007 |
63 |
5 |
p. 534-540 |
artikel |
13 |
Poor correlation between 6β-hydroxycortisol:cortisol molar ratios and midazolam clearance as measure of hepatic CYP3A activity: a comment
|
Fenske, Martin |
|
2007 |
63 |
5 |
p. 632 |
artikel |
14 |
Quality of requests for serum digoxin concentrations: experience from an Australian Regional Health Service
|
Ellington, Chris |
|
2007 |
63 |
5 |
p. 623-627 |
artikel |
15 |
Reverse transcriptase inhibitors in HIV/AIDS therapy
|
|
|
2007 |
63 |
5 |
p. 634 |
artikel |
16 |
Single-dose pharmacokinetics of levetiracetam in healthy Chinese male subjects
|
Zhao, Qian |
|
2007 |
63 |
5 |
p. 614-617 |
artikel |
17 |
The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension
|
Lefebvre, Jean |
|
2007 |
63 |
5 |
p. 575-582 |
artikel |
18 |
Unexpected relationship between plasma protein binding and the pharmacodynamics of 2-NAP, a CCK1-receptor antagonist
|
Gerskowitch, V. P. |
|
2007 |
63 |
5 |
p. 618-622 |
artikel |